Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
The retinoblastoma tumor suppressor protein (pRb) is involved in mitotic exit, promoting the arrest of myoblasts, and myogenic differentiation. However, it is unclear how permanent cell cycle exit is maintained in differentiated muscle. Using RNA interference, expression profiling, and chromatin immunoprecipitations, we show that pRb is essential for cell cycle exit and the differentiation of myoblasts and is also uniquely required to maintain this arrest in myotubes. Remarkably, we also uncover a function for the pRb-related proteins p107 and p130 as enforcers of a G2/M phase checkpoint that prevents progression into mitosis in cells that have lost pRb. We further demonstrate that pRb effects permanent cell cycle exit in part by maintaining trimethylation of histone H3 lysine 27 (H3K27) on cell cycle genes. H3K27 trimethylation silences other genes, including Cyclin D1, in a pRb-independent but polycomb-dependent manner. Thus, our data distinguish two distinct chromatin-based regulatory mechanisms that lead to terminal differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In muscle cells, loss of Rb function can result in no cell cycle re-entry45,46 or in cell cycle re-entry followed by a block in G2 (REF. 47), depending on the culture conditions.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K.-I., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,268 · cited 2×
“…it has been shown by chromatin immunoprecipitation (ChIP)–on-chip that PRC2 promotes transcriptional silencing of many regulators of cell fate, development, and differentiation, and that this repression is progressively lifted as differentiation proceeds (Bracken et al., 2006; Lee et al., 2006).”
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596 · cited 2×
“…and polycomb group (PcG) repressor complex 2, although direct evidence for a specifi c role for PcG repressor complex 2 (PRC2) in pRb-mediated transcriptional repression is lacking (Huang et al., 1991; Qian et al., 1993; Kuzmichev et al., 2002; Benevolenskaya et al., 2005; Bracken et al., 2006).”
A Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415 · cited 2×
“state is fully reversed upon mitogen stimulation (Pardee, 1974).”
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,257 · cited 2×
“…it has been shown by chromatin immunoprecipitation (ChIP)–on-chip that PRC2 promotes transcriptional silencing of many regulators of cell fate, development, and differentiation, and that this repression is progressively lifted as differentiation proceeds (Bracken et al., 2006; Lee et al., 2006).”
Epigenetic Regulation of Cellular Memory by the Polycomb and Trithorax Group Proteins
Ringrose, L., & Paro, R. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.091907 · Cited by 1,077
Li, C., & Hung Wong, W. (2001) · Genome Biology · doi:10.1186/gb-2001-2-8-research0032 · Cited by 976
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936 · cited 2×
“ChIP assays on primary myoblasts and myotubes were done similarly using two sources of primary myoblasts: with fresh cultures prepared according to a previously published method (Rando and Blau, 1994) and with cultures obtained from the lab of M. Rudnicki.”
Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro.
Bader, D., Masaki, T., & Fischman, D. A. (1982) · The Journal of cell biology · doi:10.1083/jcb.95.3.763 · Cited by 919 · cited 2×
“Antibodies The MF20 antibody against myosin heavy chain (MHC; Bader et al., 1982) and the G3G4 antibody against BrdU (George-Weinstein et al., 1993) were obtained from the Developmental Studies Hybridoma Bank.”
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
Pasini, D., Bracken, A. P., Jensen, M. R., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600402 · Cited by 916 · cited 3×
“It is thought that PRC2 is responsible for most H3K27 trimethylation in the nucleus (Erhardt et al., 2003; Pasini et al., 2004; Schoeftner et al., 2006) but, because these observations have been made using lowresolution techniques at early developmental stages, a role for other HMTases cannot currently be ruled out.”
The Polycomb-Group Gene Ezh2 Is Required for Early Mouse Development
O'Carroll, D., Erhardt, S., Pagani, M., Barton, S. C., Surani, M. A., & Jenuwein, T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4330-4336.2001 · Cited by 912
Research works printed but not linked: 5
- 2002, Cell Cycle., 1, 103
- 1995, Oncogene., 11, 801
- 1996, J. Cell. Biochem., 62, 418, 10.1002/(SICI)1097-4644(199609)62:3<418::AID-JCB12>3.0.CO;2-E · DOI
- 2004, Methods Enzymol., 376, 255
- 1996, Oncogene., 13, 1511
Cited by
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
“or in cell cycle re-entry followed by a block in G2 (Ref”
BackgroundPolycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Sauvageau, M., & Sauvageau, G. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.002 · Cited by 586
“PcG complexes also require an intact pRB-E2F complex to repress a subset of cell-cycle genes (Blais et al., 2007).”
Master Transcription Factors Determine Cell-Type-Specific Responses to TGF-β Signaling
Mullen, A. C., Orlando, D. A., Newman, J. J., Lovén, J., Kumar, R. M., Bilodeau, S., Reddy, J., Guenther, M. G., DeKoter, R. P., & Young, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.08.050 · Cited by 570
Ruijtenberg, S., & van den Heuvel, S. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1120925 · Cited by 553
“and cell cycle re-entry of terminally differentiated muscle cells.(102) Additional experimental evidence supports that silenc-”
BackgroundResult
Metadata
- Authors
- Blais, A., van Oevelen, C. J. C., Margueron, R., Acosta-Alvear, D., & Dynlacht, B. D.
- Affiliations
- University of Ottawa (CA)
- 2Department of Pathology, New York University Cancer Institute
- 3Department of Biochemistry, New York University School of Medicine, New York, NY 10016
- New York University (US)
- Corresponding author
- Blais, Alexandre
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2007-12-31
- Volume
- 179
- Issue
- 7
- Pages
- 1399-1412
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2373492
- OpenAlex
- W2026185344
- Cited by
- 126
- References
- 69
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 9 · 2016: 9 · 2015: 9 · 2014: 9 · 2013: 8 · 2012: 5
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Cancer Institute (R01CA077245, CA77245)
- National Institute of General Medical Sciences (R01GM067132, GM067132)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- retinoblastoma protein, H3K27me3, cell cycle exit, myogenesis, myotubes, p107, p130, G2/M checkpoint, Polycomb, cyclin D1, terminal differentiation, chromatin regulation
- MeSH terms
- Animals, Cell Cycle, Cell Differentiation, Cell Division, Cell Line, Histones, Lysine, Retinoblastoma Protein, G2 Phase, Cell Cycle Proteins, Genes, cdc, DNA Methylation, Gene Silencing, Gene Expression Profiling, Myoblasts, Skeletal, RNA Interference, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. https://app.cochat.ai/papers/10.1083/jcb.200705051
- The paper
- Blais, A., van Oevelen, C. J. C., Margueron, R., Acosta-Alvear, D., & Dynlacht, B. D. (2007). Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. The Journal of Cell Biology. https://doi.org/10.1083/jcb.200705051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.